Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone

[1]  M. Seiki,et al.  Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. , 1996, The American journal of pathology.

[2]  M. Caudle,et al.  IL‐1β TNF‐α, and IL‐2 in Peritoneal Fluid and Macrophage‐Conditioned Media of Women With Endometriosis , 1995 .

[3]  G. Nicolson,et al.  Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone , 1995, Clinical & Experimental Metastasis.

[4]  W. Fiers,et al.  TNF-R55-specific form of human tumor necrosis factor-alpha induces collagenase gene expression by human skin fibroblasts. , 1995, The Journal of investigative dermatology.

[5]  G. B. Schaefer,et al.  Quantitation of fibrillin immunofluorescence in fibroblast cultures in the Marfan syndrome , 1995, Clinical genetics.

[6]  D. Woolley,et al.  Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. , 1994, The Journal of clinical endocrinology and metabolism.

[7]  P. Libby,et al.  Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. , 1994, Circulation research.

[8]  J. Bruner,et al.  Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  V. Everts,et al.  Interleukin-1 alpha and epidermal growth factor synergistically enhance the release of collagenase by periosteal connective tissue in vitro. , 1993, Matrix.

[10]  H. Moriya,et al.  Establishment of a cell line from a human giant cell tumor of bone. , 1993, Clinical orthopaedics and related research.

[11]  J. Liesveld,et al.  Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire. , 1993, Experimental hematology.

[12]  L. Liotta,et al.  Reverse Transcription‐Polymerase Chain Reaction Phenotyping of Metalloproteinases and Inhibitors Involved in Tumor Matrix Invasion , 1993, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[13]  C. Beattie,et al.  Monocyte–macrophage lineage of giant cell tumor of bone. Establishment of a multinucleated cell line , 1993, Cancer.

[14]  C. Brinckerhoff,et al.  Post‐Transcriptional regulationa of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts , 1992 .

[15]  K. Suzuki,et al.  Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone. , 1992, The American journal of pathology.

[16]  L. Matrisian.  The matrix‐degrading metalloproteinases , 1992, Journal of neuro-oncology.

[17]  A. Strongin,et al.  Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. , 1992, The Journal of biological chemistry.

[18]  Y. Sasaguri,et al.  Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. , 1991, Atherosclerosis.

[19]  M. Kuwano,et al.  The response to epidermal growth factor of human maxillary tumor cells in terms of tumor growth, invasion and expression of proteinase inhibitors , 1991, International journal of cancer.

[20]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[22]  W. Stetler-Stevenson.  Type IV collagenases in tumor invasion and metastasis , 1990, Cancer and Metastasis Reviews.

[23]  R. Pyeritz,et al.  Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. , 1990, The New England journal of medicine.

[24]  S. Pileri,et al.  Giant Cell Tumor of Bone: A Model for the in Vitro Human Osteoclast Characterization , 1989, Tumori.

[25]  K. Suzuki,et al.  Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin). , 1988, The Biochemical journal.

[26]  G. Nicolson,et al.  Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. , 1987, Cancer research.

[27]  G. Zajicek,et al.  Growth rate analysis of lung metastases from histologically benign giant cell tumor of Bone , 1987, Cancer.

[28]  S. Krane,et al.  Characterization of cells from human giant cell tumors of bone. , 1986, Clinical orthopaedics and related research.

[29]  M. Horton,et al.  Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. , 1985, Cancer research.

[30]  W. Enneking,et al.  Giant-cell tumor of bone with pulmonary metastases. , 1985, The Journal of bone and joint surgery. American volume.

[31]  M. Rock,et al.  Metastases from histologically benign giant-cell tumor of bone. , 1984, The Journal of bone and joint surgery. American volume.

[32]  R. Caballes.  The mechanism of metastasis in the so-called "benign giant cell tumor of bone". , 1981, Human pathology.

[33]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Gollahon,et al.  Macrophages in giant cell tumours of bone , 1978, The Journal of pathology.

[35]  H. Takeuchi,et al.  In vitro bone resorption by isolated multinucleated giant cells from giant cell tumour of bone: Light and electron microscopic study , 2005, Virchows Archiv A.

[36]  K. Tryggvason,et al.  Type IV collagenases in invasive tumors , 2005, Breast Cancer Research and Treatment.

[37]  L. Matrisian,et al.  Matrix degrading metalloproteinases , 2005, Journal of Neuro-Oncology.

[38]  S. Komiya,et al.  Prognostic factors in giant cell tumor of bone a modified histological grading system useful as a guide to prognosis , 2004, Archives of orthopaedic and traumatic surgery.

[39]  H. Yoshida,et al.  Giant cell tumor of bone , 2004, Virchows Archiv A.

[40]  T. T. Chen,et al.  IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. , 1995, American journal of reproductive immunology.

[41]  Y. Okada,et al.  Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[42]  D. Rifkin,et al.  Biology and biochemistry of proteinases in tumor invasion. , 1993, Physiological reviews.

[43]  C. Brinckerhoff,et al.  Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. , 1992, Journal of cellular biochemistry.

[44]  A. Huvos.  Bone tumors, diagnosis, treatment, and prognosis , 1979 .